Does the measurement of N-terminal proANF predict long-term cardiovascular mortality and development of heart failure in patients after myocardial infarction?
N-terminal proANF serves as an independent prognostic biomarker for cardiovascular mortality and heart failure following myocardial infarction.
The measurement of N-terminal proANF supplements presently used clinical and objective assessments and provides an important independent predictor of prognosis with respect to cardiovascular mortality and development of heart failure.
Hall et al. (1994) studied this question.